Observing the effects and progression of chronic pancreatitis
Official title: Natural Course and Therapeutic Effect of Chronic Pancreatitis: a Prospect Cohort Study
Run by Changhai Hospital · NCT06925204 · Data updated 2026-11-12
This study is trying to gather detailed information from people with chronic pancreatitis to see how the condition affects them and improve their diagnosis and treatment.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Changhai Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | April 13, 2025 |
| Main results expected | December 1, 2035 |
| Study ends | December 31, 2035 |
| Registry record updated | April 15, 2025 |
| Trial ID | NCT06925204 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with chronic pancreatitis.
✕Probably not a fit
Patients who refuse to sign informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to create a prospective cohort of patients with chronic pancreatitis (CP) to gather comprehensive data that will inform clinical practices. It will collect detailed demographic information, clinical data, medical imaging, biological samples, and follow-up information from participants. The goal is to optimize diagnostic and treatment strategies for CP, which is characterized by abdominal pain and pancreatic dysfunction, significantly affecting patients' quality of life.
Why it matters
Potential benefit: If successful, this study could lead to improved management and treatment strategies for patients suffering from chronic pancreatitis.
How similar studies have gone: While this study is observational and aims to establish a cohort, similar studies have shown that comprehensive data collection can lead to significant advancements in understanding chronic conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with chronic pancreatitis. Exclusion Criteria: * Patients who refuse to sign informed consent.
Where it's running
-
Changhai Hospital
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Lianghao Hu, M.D.
- Email: lianghao-hu@smmu.edu.cn
- Phone: +86-13817593520
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
CBT-248 safety in healthy adults for chronic pancreatitis support
This early study tests CBT-248 in healthy adults to see if it is safe, how it behaves in the body, and whether meals affect its levels.
-
Blood protein biomarkers to help diagnose pancreatic cancer in adults
This study tests whether blood protein biomarkers can help detect pancreatic ductal adenocarcinoma and tell it apart from chronic pancreatitis and mucinous pancreatic lesions, and whether combining markers with CA 19-9 improves accuracy.
-
Relieving a blocked pancreatic duct in chronic pancreatitis
This pilot study tests whether clearing a blocked pancreatic duct with endoscopy can help people with chronic pancreatitis who have mild symptoms.
-
Understanding brain changes in chronic pancreatitis pain
This study tests whether central nervous system changes and neuropsychological factors help explain persistent pain in adults with chronic pancreatitis.
-
EUS-guided pancreaticobiliary procedures with the RIVOS access device
This study tests how the RIVOS EUS access device performs during interventional procedures for pancreatic and bile duct problems in adults.
-
Odesa Criteria 2026: tests for autoimmune pancreatitis diagnosis
This study checks if the OC26 scoring system can accurately diagnose autoimmune pancreatitis in adults who may have AIP or related pancreatic diseases.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.